why doesn't tirzepatide work for me Am I Not Losing Weight on Tirzepatide? Why Is Tirzepatide Not Working

Carry a prescription and keep original packaging

Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: a post hoc analysis of the SURPASS-1 to 5 studies

Stat Med 32(19):33883414 Acknowledgements The authors would like to thank Jennifer Winnie and Vinay Mehta employees of Eli Lilly and Company for facilitating data acquisition for this study

Comparative Analysis Mechanism Comparison Factor Mazdutide Tirzepatide Retatrutide Agonist Type Dual Dual Triple Second Receptor Glucagon GIP Both Developer Innovent/Lilly Eli Lilly Eli Lilly FDA Approved No Yes No (under review) Primary Trial Region China Global Global Research Application Selection When to consider Mazdutide: Research specifically examining glucagon pathway contributions without GIP confounding Studies comparing GLP-1/glucagon vs

It works by activating three different receptors in the body (GLP-1, GIP, and glucagon receptors)

However, the metabolic changes it triggers, including glycogen depletion, blood sugar normalization, and dietary shifts, can indirectly increase urination frequency